ロード中...
T cell receptor grafting allows virological control of hepatitis B virus infection
T cell therapy is a promising means to treat chronic hepatitis B virus (HBV) infection and HBV-associated hepatocellular carcinoma. T cells engineered to express an HBV-specific T cell receptor (TCR) may cure an HBV infection upon adoptive transfer. We investigated the therapeutic potential and safe...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597229/ https://ncbi.nlm.nih.gov/pubmed/31039136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI120228 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|